Zobrazeno 1 - 10
of 533
pro vyhledávání: '"Hebert A. Vargas"'
Autor:
Sungmin Woo, Anton S. Becker, Jeeban P. Das, Soleen Ghafoor, Yuki Arita, Nicole Benfante, Natalie Gangai, Min Yuen Teo, Alvin C. Goh, Hebert A. Vargas
Publikováno v:
Cancer Imaging, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Neoadjuvant chemotherapy (NAC) before radical cystectomy is standard of care in patients with muscle-invasive bladder cancer (MIBC). Response assessment after NAC is important but suboptimal using CT. We assessed MRI without vs. w
Externí odkaz:
https://doaj.org/article/9576dd4e7b5a4a33a57dc6c43b8a23d7
Autor:
Monica Cheng, Cihan Duzgol, Tae-Hyung Kim, Soleen Ghafoor, Anton S. Becker, Pamela I. Causa Andrieu, Natalie Gangai, Hui Jiang, Abraham A. Hakimi, Hebert A. Vargas, Sungmin Woo
Publikováno v:
Cancer Imaging, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Objective To evaluate MRI features of sarcomatoid renal cell carcinoma (RCC) and their association with survival. Methods This retrospective single-center study included 59 patients with sarcomatoid RCC who underwent MRI before nephrectomy d
Externí odkaz:
https://doaj.org/article/c00e9228b82f418b9d6cddad01f2697a
Autor:
Sungmin Woo, Abdallah Araji, Mohammad Ali El Amine, Natalie Gangai, Elizabeth Acquafredda, Anita P. Price, Tanya M. Trippett, Hedvig Hricak, Hebert Alberto Vargas, Gerald G. Behr
Publikováno v:
Cancer Imaging, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background To assess the spectrum and frequency of modalities used for emergency room (ER) imaging and their findings in pediatric cancer patients and assess their relationship with survival. Methods Consecutive pediatric cancer patients tha
Externí odkaz:
https://doaj.org/article/be3f9a20b1654d40a08543e0bfc6187c
Publikováno v:
Cancer Imaging, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Backgound Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a subtype of RCC that is increasingly recognized pathologically. The aim of this study was to evaluate the imaging features of FH-RCC on computed tomography (CT), magnet
Externí odkaz:
https://doaj.org/article/a66fb918e39b407fa3cda560ef2d75ca
Autor:
Sungmin Woo, Soleen Ghafoor, Anton S. Becker, Sangwon Han, Andreas G. Wibmer, Hedvig Hricak, Irene A. Burger, Heiko Schöder, Hebert Alberto Vargas
Publikováno v:
European Journal of Hybrid Imaging, Vol 4, Iss 1, Pp 1-15 (2020)
Abstract Purpose Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has shown promise for detecting nodal and distant prostate cancer (PCa) metastases. However, its performance for local tumor staging is not as well establishe
Externí odkaz:
https://doaj.org/article/dd273852ed78468681995adc581d1d69
Publikováno v:
Life, Vol 12, Iss 4, p 552 (2022)
Prostate MRI is an integral part of the clinical work-up in biopsy-naïve patients with suspected prostate cancer, and its use has been increasing steadily over the last years. To further its general availability and the number of men benefitting fro
Externí odkaz:
https://doaj.org/article/5b58b9131bde43b39c56ccd834998647
Autor:
David J. Kwiatkowski, Gopa Iyer, Martin H. Voss, James J. Harding, Hebert A. Vargas, Geoffrey I. Shapiro, Anne Sisk, David M. Hyman, Junko Tsuji, Lynette M. Sholl, Katherine E. Kargus, Jennifer Hedglin, Matthew I. Milstein, Ketki Bhushan, Solida Pruitt-Thompson, Khanh T. Do, Krinio Giannikou, Katarzyna Klonowska, Elio Adib
Table S3. Toxicities (any level) occurring in at least two patients, grouped by CTCAE v4.0 categories. For patients with more than one adverse event per category, only the highest-grade event was counted.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43be27b2858b437996e4d0c2a2f5fd63
https://doi.org/10.1158/1078-0432.22480322
https://doi.org/10.1158/1078-0432.22480322
Autor:
Oguz Akin, Hedvig Hricak, Chaya S. Moskowitz, Junting Zheng, Yousef Mazaheri, Hebert Alberto Vargas, Asim Afaq, Olivio F. Donati
Patient Demographics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8391ddc6672508ae9d9ff8ec942cdc
https://doi.org/10.1158/1078-0432.22454910
https://doi.org/10.1158/1078-0432.22454910
Autor:
David J. Kwiatkowski, Gopa Iyer, Martin H. Voss, James J. Harding, Hebert A. Vargas, Geoffrey I. Shapiro, Anne Sisk, David M. Hyman, Junko Tsuji, Lynette M. Sholl, Katherine E. Kargus, Jennifer Hedglin, Matthew I. Milstein, Ketki Bhushan, Solida Pruitt-Thompson, Khanh T. Do, Krinio Giannikou, Katarzyna Klonowska, Elio Adib
Supplementary Methods File
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10ef00fe45b9ce87b96632e809265c98
https://doi.org/10.1158/1078-0432.22480331.v1
https://doi.org/10.1158/1078-0432.22480331.v1
Autor:
David J. Kwiatkowski, Gopa Iyer, Martin H. Voss, James J. Harding, Hebert A. Vargas, Geoffrey I. Shapiro, Anne Sisk, David M. Hyman, Junko Tsuji, Lynette M. Sholl, Katherine E. Kargus, Jennifer Hedglin, Matthew I. Milstein, Ketki Bhushan, Solida Pruitt-Thompson, Khanh T. Do, Krinio Giannikou, Katarzyna Klonowska, Elio Adib
Purpose:This was a multicenter, histology-agnostic, single-arm prospective phase II trial of therapeutic activity of everolimus, an oral mTORC1 inhibitor, in patients with advanced solid tumors that harbored TSC1/TSC2 or MTOR mutations.Patients and M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa0191ff343379a0a91c7adc522313e
https://doi.org/10.1158/1078-0432.c.6530420
https://doi.org/10.1158/1078-0432.c.6530420